Why Haven't Other Operators Followed Trulieve?
> **Revision Notice (2026-06-24):** This article underwent an article-wide revision due to inaccurate information identified and prompted for correction by a human reviewer.
Trulieve's restructuring was tied to a specific strategic objective: qualifying for a U.S. exchange uplisting after the federal government's April 2026 decision to move state-licensed medical marijuana into Schedule III.
The company completed a corporate restructuring that deconsolidated operations in markets serving both medical and adult-use customers. After that transaction, Trulieve said its remaining consolidated operations consisted only of state-licensed medical marijuana facilities, a structure that supported its NYSE listing.
Most operators have not announced similar moves. One reason is that a comparable restructuring would likely require substantial legal, accounting, and operational work. Separating mixed-use operations can involve changes to corporate entities, financial reporting, governance structures, and the treatment of assets tied to both medical and adult-use markets. For companies without an immediate listing-related objective, those costs may outweigh the short-term benefit.
Many multistate operators also continue to run businesses built around vertically integrated assets that serve both medical and adult-use demand. Preserving those structures may remain the simpler course unless exchange access, financing considerations, or some other strategic priority creates a stronger incentive to reorganize.
For now, Trulieve's move appears to reflect a company-specific decision shaped by uplisting, exchange eligibility, and the post-rescheduling treatment of medical cannabis operations. Other operators may eventually evaluate similar changes, but there is not yet much public indication that a broader wave of comparable restructuring is underway.